Phagocyte enhancement therapy for atherosclerosis
作者： Ira Tabas
DOI:
关键词:
摘要: Compounds that increase phagocytosis of apoptotic macrophages or necrotic cells are associated with advanced atherosclerotic lesions useful for treating atherosclerosis. Methods provided identifying such compounds and preventing atherosclerosis by increasing lesions.
lens.org 参考文章(22)
Ira Tabas, Methods for preventing acute clinical vascular events in a subject ,(2004)
Richard A. Hines, Process for forming a porous drug delivery layer ,(2003)
Werner Skuballa, John G. Bauman, William J. Guilford, John F. Parkinson, Babu Subramanyam, Lipoxin a4 analogs ,(2002)
Leonid G. Ber, Phagocytosis activator compositions and their use ,(1997)
Andrea J. Tenner, Ronald R. Nepomuceno, Host defense enhancement ,(1996)
Daniel Cox, E. Cheng, Stent for treating vulnerable plaque ,(2003)
Rangarajan Sundar, Kaushik Patel, Peiwen Cheng, Kishore Udipi, Drug-polymer coated stent with pegylated styrenic block copolymers ,(2003)
Thomas R. Matthews, Elizabeth B. Fraser-Smith, Deborah A. Eppstein, Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides ,(1982)
Annabelle Rodriguez, Paul S. Bachorik, Siok-Bi Wee, Novel Effects of the Acyl-Coenzyme A:Cholesterol Acyltransferase Inhibitor 58-035 on Foam Cell Development in Primary Human Monocyte–Derived Macrophages Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 19, pp. 2199- 2206 ,(1999) , 10.1161/01.ATV.19.9.2199
Thomas R. Cech, Arthur J. Zaug, Cheryl Grosshans, Felicia L. Murphy, Rna ribozyme restriction endoribonucleases and methods ,(1990)